Currently out of the existing stock ratings of Josh Schimmer, 132 are a BUY (86.27%), 19 are a HOLD (12.42%), 2 are a SELL (1.31%).

Josh Schimmer

Work Performance Price Targets & Ratings Chart

Analyst Josh Schimmer, currently employed at CANTOR FITZGERALD, carries an average stock price target met ratio of 52.84% that have a potential upside of 48.61% achieved within 324 days.

Josh Schimmer’s has documented 647 price targets and ratings displayed on 42 stocks. The coverage is on Healthcare, Industrials sectors.

Most recent stock forecast was given on RNA, Avidity Biosciences at 22-Sep-2025.

Wall Street Analyst Josh Schimmer

Analyst best performing recommendations are on INSM (INSMED).
The best stock recommendation documented was for INSM (INSMED) at 8/16/2017. The price target of $28 was fulfilled within 21 days with a profit of $16.29 (139.11%) receiving and performance score of 66.24.

Average potential price target upside

of $62.54 (21.92%) on BIIB (BIOGEN).
of $62.48 (52.23%) on AMGN (AMGEN).
of $57.61 (48.74%) on ASND (ASCENDIS PHARMA AS).

ALXN Alexion Pharmaceuticals BLU BELLUS Health DICE Dice Molecules Holdings LLC FDMT 4D Molecular Therapeutics HRTX Heron Therapeuti INSM Insmed IONS Ionis Pharmaceuticals MDGL Madrigal Pharmaceuticals REGN Regeneron Pharmaceuticals RGNX Regenxbio SPRO Spero Therapeutics VTYX Ventyx Biosciences CABA Cabaletta Bio ICVX Icosavax INBX Inhibrx ADMS Adamas Pharmaceuticals GOSS Gossamer Bio RNA Avidity Biosciences ZYME Zymeworks Common Stock AKRO Akero Therapeutics BBIO BridgeBio Pharma CRNX Crinetics Pharmaceuticals ERAS Erasca INCY yte KDNY Chinook Therapeutics KRYS Krystal Biotech ASND Ascendis Pharma AS PMVP Pmv Pharmaceuticals LBPH Longboard Pharmaceuticals MIRM Mirum Pharmaceuticals XENE Xenon Pharmaceuticals ALEC Alector JANX Janux Therapeutics CGON CG Oncology, Common stock SEPN Septerna, Common Stock SPRY ARS Pharmaceuticals ABBV AbbVie AXON Axon Enterprise CBAY Cymabay Therapeu CMPS Compass Pathways Plc DVAX Dynavax Technologies MITO Stealth BioTherapeutics Corp

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hartaj Singh (OPPENHEIMER)